CNTX
Price
$0.20
Change
+$0.01 (+5.26%)
Updated
Nov 9, 03:13 PM (EDT)
Capitalization
17.78M
135 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.18
Change
+$0.03 (+2.63%)
Updated
Nov 9, 03:39 PM (EDT)
Capitalization
238.18M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs PROK

CNTX vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CNTX vs. PROK commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and PROK is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CNTX with price predictions
Nov 06, 2026

CNTX's Indicator enters downward trend

The Aroon Indicator for CNTX entered a downward trend on November 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 278 similar instances where the Aroon Indicator formed such a pattern. In 262 of the 278 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNTX's RSI Indicator exited the oversold zone, 35 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Moving Average Convergence Divergence (MACD) for CNTX just turned positive on November 04, 2026. Looking at past instances where CNTX's MACD turned positive, the stock continued to rise in 38 of 43 cases over the following month. The odds of a continued upward trend are 88%.

Following a +1.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNTX advanced for three days, in 211 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

CNTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.466) is normal, around the industry mean (3.498). P/E Ratio (-0.403) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. CNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for PROK with price predictions
Nov 06, 2026

PROK's Indicator enters downward trend

The Aroon Indicator for PROK entered a downward trend on November 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 183 similar instances where the Aroon Indicator formed such a pattern. In 160 of the 183 cases the stock moved lower. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PROK as a result. In 74 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

The Moving Average Convergence Divergence Histogram (MACD) for PROK turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 43 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

PROK moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PROK crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PROK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PROK's RSI Oscillator exited the oversold zone, 24 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 69 cases where PROK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

Following a +11.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where PROK advanced for three days, in 200 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

PROK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.270) is normal, around the industry mean (3.498). P/E Ratio (-2.073) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (344.828) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. PROK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PROK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
CNTXPROK
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
89%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (CNTX: $0.19 vs. PROK: $1.14)
Brand notoriety: CNTX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 117% vs. PROK: 65%
Market capitalization -- CNTX: $17.78M vs. PROK: $238.18M
CNTX [@Biotechnology] is valued at $17.78M. PROK’s [@Biotechnology] market capitalization is $238.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green while PROK’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 1 green, 4 red.
According to our system of comparison, CNTX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 2 bearish.
  • PROK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than PROK.

Price Growth

CNTX (@Biotechnology) experienced а +2.33% price change this week, while PROK (@Biotechnology) price change was -11.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 24, 2027.

PROK is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (+2.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with ELTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then ELTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+2.98%
ELTX - CNTX
42%
Loosely correlated
+7.86%
NMRA - CNTX
39%
Loosely correlated
+3.35%
PROK - CNTX
29%
Poorly correlated
+7.04%
TRAW - CNTX
27%
Poorly correlated
+0.77%
MREO - CNTX
27%
Poorly correlated
+0.93%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MUJ11.780.21
+1.82%
Blackrock Muniholdings NEW Jersey Quality Fund
MEMX40.720.57
+1.41%
Matthews Emerging Markets ex China Active ETF (MEMX)
BRAZ27.270.23
+0.86%
Global X Brazil Active ETF (BRAZ)
BBBS50.19-0.02
-0.04%
BondBloxx BBB Rated 1-5 Year Corporate Bond ETF (BBBS)
DFSD47.01-0.05
-0.11%
Dimensional Short-Duration Fixed Income ETF (DFSD)